NLS Pharmaceutics AG

NASDAQ: NLSP · Real-Time Price · USD
2.54
-0.07 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
2.58
1.58%
After-hours: Aug 15, 2025, 07:55 PM EDT

NLS Pharmaceutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-2.04M -4.56K -7.61M -7.85M -8.64M -7.34M -4.6M
Depreciation & Amortization
5.7K 5.70 5.7K 5.7K 5.7K 5.03K 5.02K
Stock-Based Compensation
n/a 104.39 60.52 22.73 n/a n/a n/a
Other Working Capital
449.46K 465.79 -474.33K 794.6K 195.94K 903.4K -1.78M
Other Non-Cash Items
99.42K 1.6K -683.26K 1.15M -784.54K -1.15M 3.63M
Deferred Income Tax
n/a n/a 728.28K -160.01K n/a n/a n/a
Change in Working Capital
400.21K 465.79 265.42K 646.02K 980.79K 2.1M -5.27M
Operating Cash Flow
-1.53M -2.39K -7.3M -6.21M -7.67M -5.2M -9.73M
Capital Expenditures
-2 n/a n/a n/a n/a -6.8K -32.76K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a -7.6M 4.08M -6.8K -32.76K
Debt Repayment
-194.72K n/a n/a n/a n/a n/a -1.43K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.63K n/a 13.81M 3.59K 3.55M 16.79M
Financial Cash Flow
1.19M 1.63K n/a 13.81M 3.59M 3.55M 16.79M
Net Cash Flow
-344.92K 896.03K -7.3M 7.59M -4.08M -1.66M 7M
Free Cash Flow
-1.53M -2.39K -7.3M -6.21M -7.67M -5.21M -9.77M